JavaScript may be disabled in your browser. Please enable JavaScript for access to all site features.

Home
>
Artists
>
XVIVO

XVIVO

Alpha-1 Antitrypsin Deficiency (AATD) Animation

mRNAs as Medicines

medical animation of We collaborated with Max Hodak, the CEO of Science Corporation, to create a 3D animation to accurately and beautifully depict their breakthrough biohybrid technology. The animation showcases the architecture of their system and illustrates how their innovative technology facilitates communication to and from the brain.

Science Biohybrid Animation

XVIVO and Korro Bio continued their partnership to create an animation for Korro’s RNA editing oligonucleotide candidate for alpha-1 antitrypsin deficiency (AATD) from their proprietary OPERA™ platform. The purpose of the animation was to illustrate the unmet need for AATD patients, the role of the protein AAT in the disease, and the promise of Korro’s RNA editing candidate.

Keywords: Animation, 3D, Video, Professional Education, Biotechnology, Genetics, Molecular Biology, Mechanism of Action (MOA)

XVIVO